5VB fundamentals
An in-depth look to NYKODE THERAPEUTICS ASA operating, investing, and financing activities
5VB free cash flow for Q2 24 is -10 M EUR. For 2023, 5VB free cash flow was -84.23 M EUR and operating cash flow was -82.44 M EUR.
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM